Literature DB >> 35733006

Capillary Gel Electrophoresis (CGE) for Quality Control of Plasmid DNA in Gene Therapy: Quality Control of 20 Years Stored GMP-Grade Plasmid DNA.

Marco Schmeer1, Martin Schleef2, Ram Shankar2, Dennis Kobelt3, Wolfgang Walther3,4.   

Abstract

Plasmid DNA in any form (plasmid DNA, minicircle, miniplasmid) does experience renewed and increasing attention for use in gene therapy and DNA vaccination. For such applications, stability analyses and quality control are essential prerequisites for clinical use. In this context we analyzed the stability of good manufacturing practice (GMP)-grade pCMVβ reporter plasmid DNA by capillary gel electrophoresis. The plasmid DNA was produced for a clinical gene transfer study for treatment of malignant melanoma. The pCMVβ plasmid DNA was stored at -20 °C for 20 years under continuous, controlled monitoring. Another plasmid., pCMV-Luc, stored for 15 years, served as reference. The stability of plasmid DNA was analyzed by capillary gel electrophoresis (CGE) and functionally tested in vitro by LacZ functional assay. In this chapter we provide the detailed description of CGE and functional analysis of the GMP-grade pCMVβ and also pCMV-Luc plasmid DNA. By this the proportion of open circular and supercoiled or covalently closed circular forms of plasmid DNA is analyzed. Functionality of the plasmid was tested by in vitro transfection and LacZ functional assay. In result of this, the 20-year-old plasmid DNA showed topology and expression performance, which revealed significant alterations in topology while maintaining functionality regarding transgene expression. Therefore, stable storage conditions are effective to mainly preserve the integrity of the plasmid DNA as important parameter for long-term storage of, for example, reference samples.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CGE analysis; Clinical trial; Covalently closed circular; GMP; Plasmid DNA; Supercoil

Mesh:

Substances:

Year:  2022        PMID: 35733006     DOI: 10.1007/978-1-0716-2441-8_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Gene therapy clinical trials worldwide to 2017: An update.

Authors:  Samantha L Ginn; Anais K Amaya; Ian E Alexander; Michael Edelstein; Mohammad R Abedi
Journal:  J Gene Med       Date:  2018-04-19       Impact factor: 4.565

2.  pEPito: a significantly improved non-viral episomal expression vector for mammalian cells.

Authors:  Rudolf Haase; Orestis Argyros; Suet-Ping Wong; Richard P Harbottle; Hans J Lipps; Manfred Ogris; Terese Magnusson; Maria G Vizoso Pinto; Jürgen Haas; Armin Baiker
Journal:  BMC Biotechnol       Date:  2010-03-15       Impact factor: 2.563

Review 3.  DNA vaccines against COVID-19: Perspectives and challenges.

Authors:  Marcelle Moura Silveira; Gustavo Marçal Schmidt Garcia Moreira; Marcelo Mendonça
Journal:  Life Sci       Date:  2020-12-19       Impact factor: 6.780

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.